Selected Publications
Himeless JR, Holton J, Vittorio C, Rook A, Haun P, Villasenor-Park J, Samimi S, Kim E.: Recent trends in skin directed and self-administered systemic treatment costs in the United States for Cutaneous T Cell Lymphoma JAMA Dermatol 88 (3): 680-683,2023.
Weiner DM, Clark AK, Bhansali R, Pappas-Taffer L, Barta SK, Villasenor-Park J, Haun PL, Vittorio CC, Rook AH, Kim EJ, Samimi SS.: Usage and Safety of Topical Tacrolimus in Patients with Mycosis Fungoides Clin Exp Dermatol. 47 (6): 1200-1201,2022.
Marsch A, Khodosh R, Porter M, Raad J, Samimi S, Schultz B, Chaney Strowd L, Vera L, Wong E, Smith GP.: Implementing Patient Safety and Quality Improvement in Dermatology Part 2: Quality Improvement Science J Am Acad Dermatol. S0190-9622 (22): 00208-0,2022.
Marsch A, Khodosh R, Porter M, Raad J, Samimi S, Schultz B, Chaney Strowd L, Vera L, Wong E, Smith GP.: Implementing Patient Safety and Quality Improvement in Dermatology Part 1: Patient Safety Science J Am Acad Dermatol. S0190-9622 (22): 00207-9,2022.
Wanat KA, Perelygina L, Chen MH, Hao L, Abernathy E, Bender NR, Shields BE, Wilson BDE, Crosby D, Routes J, Samimi SS, Haun PL, Sokumbi O, Icenogle JP, Sullivan KE, Rosenbach M, Drolet BA.: Association of persistent rubella virus with idiopathic skin granulomas in clinically immunocompetent adults JAMA Dermatol 158 (6): 626-33,2022.
Samimi S, Choi J, Rosman IS, Rosenbach M.: Impact of COVID-19 on Dermatology Residency Dermatol Clin. 39 (4): 609-618,2021.
Weiner DM, Clark AK, Moon AT, Haun PL, Samimi SS.: A case of nevoid follicular mucinosis in a child JAAD Case Rep 18 : 29-32,2021.
Shields B, Perelygina L, Samimi S, Haun P, Leung T, Abernathy E, Chen M, Hao L, Icenogle J, Drolet B, Wilson B, Bryer J, England R, Blumberg E, Wanat K, Sullivan K, Rosenbach M.: Granulomatous Dermatitis Associated With Rubella Virus Infection in an Adult With Immunodeficiency JAMA Dermatol. 157 (7): 842-847,2021.
Lewis D, Haun P, Samimi S, Vittorio C, Villasenor-Park J, Barta S, Landsburg D, Svoboda J, Nasta S, Schuster S, Rook A, Kim E.: Brentuximab Vedotin for relapsed/refractory sezary syndrome: a single center experience JAMA Dermatol. 157 (3): 317-321,2021.
Durgin J, Jariwala N, Wysocka M, Zhang K, Maity A, Benoit B, Plastaras J, Lewis D, Rosenthal J, Teague J, Berg S, Del Guzzo C, Kim E, Vittorio C, Haun P, Samimi S, illasenor-Park J, Clark R, Rook A.: Low or Conventional-Dose TSEBT with Concomitant Immunotherapy Can Produce Durable Responses in Sezary Syndrome: Clinical, Immunological and moledcular Analysis. JAMA Dermatol. 157 (1): 90-95,2021.
Academic Contact Information
Department of Dermatology
2 Gates Building
3600 Spruce Street
Philadelphia,
PA
19104
Phone: 215-662-2194
Patient appointments: 800-789-7366